Authors: Ardeshna, KM Corney, CP Ings, SJ Watts, MJ Linch, DC Devereux, S

Citation: Km. Ardeshna et al., A clinically applicable method for the ex vivo generation of antigen-presenting cells from CD34(+) progenitors, VOX SANGUIN, 79(1), 2000, pp. 46-52

Authors: Watts, MJ Ings, SJ Flynn, M Dodds, D Goldstone, AH Linch, DC

Citation: Mj. Watts et al., Remobilization of patients who fail to achieve minimal progenitor thresholds at the first attempt is clinically worthwhile, BR J HAEM, 111(1), 2000, pp. 287-291

Authors: Watts, MJ Ings, SJ Leverett, D MacMillan, A Devereux, S Goldstone, AH Linch, DC

Citation: Mj. Watts et al., ESHAP and G-CSF is a superior blood stem cell mobilizing regimen compared to cyclophosphamide 1.5 g m(-2) and G-CSF for pre-treated lymphoma patients: a matched pairs analysis of 78 patients, BR J CANC, 82(2), 2000, pp. 278-282

Authors: Peggs, KS Ings, SJ Kottaridis, PD Yong, K Williams, CD Goldstone, AH Mackinnon, S

Citation: Ks. Peggs et al., Cytomegalovirus infection and disease after autologous CD34-selected peripheral blood stem cell transplantation for multiple myeloma: no evidence of increased incidence based on polymerase-chain-reaction monitoring, BLOOD, 96(1), 2000, pp. 369-370

Authors: Yong, K Fahey, A Reeve, L Nicholls, C Thomas, NSB Pizzey, A Ings, SJ Watts, MJ Linch, DC

Citation: K. Yong et al., Cord blood progenitor cells have greater transendothelial migratory activity and increased responses to SDF-1 and MIP-3 beta compared with mobilized adult progenitor cells, BR J HAEM, 107(2), 1999, pp. 441-449